For the first time since the US Supreme Court ruled last year that socalled paytodelay deals may be subject to greater antitrust scrutiny the US Federal Trade Commission has filed a lawsuit charging drug makers with violating antitrust laws and hurting consumers in their collective pocketbooks Specifically the agency charged several drug makers  including AbbVie Abbott Laboratories which spun off AbbVie and Teva Pharmaceuticals  for striking deals that delayed the availability of the widely promoted AndroGel testosterone replacement therapy a  billion seller